Combination therapy prevents amyloid-dependent and -independent structural changes.
Neuropathological features of Alzheimer's disease (AD) are recapitulated in transgenic mice expressing familial AD-causing mutations, but ectopic transgene overexpression makes it difficult to relate these abnormalities to disease pathogenesis. Alternatively, the APP/PS-1 double knock-in (DKI) mouse produces mutant amyloid precursor protein (APP) and presenilin-1 (PS-1) with normal levels and regulatory controls. Here, we investigated effects of amyloid on brain structure and neuroplasticity by vaccinating DKI mice with amyloid-β starting at 8 months of age. At 14 months, vaccination blocked cerebral amyloid deposition and its attendant microglial activation. Neuropil abnormalities were pronounced only within plaques, and included circumscribed loss and dysmorphology of axons, dendrites, terminals and spines. Blockade of amyloid deposition restored neuropil integrity. Amyloid removal did not rescue reductions in the hippocampal neural progenitor and neuroblast populations, but adding 1 month of voluntary exercise to amyloid-β vaccination markedly stimulated hippocampal neurogenesis. These results identify amyloid-dependent and -independent structural changes in the DKI mouse model of AD. Combining exercise with amyloid-directed immunotherapy produces greater restoration of brain structure and neuroplasticity than is achieved with either maneuver alone.
Department of Neurosurgery, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
Gauri
G
Malthankar-Phatak
Shane
S
Poplawski
Nikhil
N
Toraskar
Robert
R
Siman
D016229:Amyloid beta-Peptides / Q000494:pharmacology / Q000627:therapeutic use*; D016564:Amyloid beta-Protein Precursor / Q000235:genetics; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000473:pathology*; D003131:Combined Modality Therapy; D005260:Female; D055879:Gene Knock-In Techniques; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D009473:Neuronal Plasticity / Q000502:physiology; D010805:Physical Conditioning, Animal / Q000379:methods / Q000639:trends*; D058225:Plaque, Amyloid / Q000235:genetics / Q000473:pathology* / Q000517:prevention & control*; D053764:Presenilin-1 / Q000235:genetics
D016229:Amyloid beta-Peptides; D016564:Amyloid beta-Protein Precursor; D053764:Presenilin-1
Hippocampus. 2010 Aug;20(8):971-9
19714567
Neuroscience. 2004;129(3):615-28
15541883
Arch Neurol. 2001 Mar;58(3):498-504
11255456
Cell. 2009 Nov 13;139(4):814-27
19914173
Prog Clin Biol Res. 1989;317:849-56
2532371
J Neurosci. 2007 Jun 20;27(25):6771-80
17581964
J Neuropathol Exp Neurol. 2001 Aug;60(8):753-8
11487049
Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):3228-33
10077666
Lancet Neurol. 2010 Jan;9(1):119-28
20083042
Ann N Y Acad Sci. 2000;920:274-84
11193164
J Comp Neurol. 2006 Mar 1;495(1):70-83
16432899
J Biol Chem. 2001 Nov 30;276(48):44736-43
11574534
Ann Neurol. 1991 Oct;30(4):572-80
1789684
J Alzheimers Dis. 2006;9(3 Suppl):425-32
16914881
Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10273-8
11517335
J Biol Chem. 1995 Nov 24;270(47):28257-67
7499323
Nat Neurosci. 1999 Mar;2(3):266-70
10195220
J Neurosci. 2009 Aug 12;29(32):10144-52
19675248
J Alzheimers Dis. 2006;9(3 Suppl):133-49
16914852
J Neurosci. 2000 Dec 1;20(23):8717-26
11102478
Exp Neurol. 1988 Nov;102(2):264-8
2460367
Neuroscience. 1994 Jun;60(3):607-19
7936190
J Neurosci Res. 1988 Sep;21(1):18-24
3216409
Proc Natl Acad Sci U S A. 1983 Oct;80(19):6126-30
6577472
J Neurosci. 2009 Nov 11;29(45):14108-19
19906959
J Alzheimers Dis. 2008 Dec;15(4):555-69
19096156
J Pharmacol Sci. 2005 Apr;97(4):461-71
15821343
DNA Cell Biol. 2001 Nov;20(11):731-6
11788051
FEBS Lett. 1996 Oct 7;394(3):279-84
8830658
J Mol Neurosci. 2001 Oct;17(2):101-18
11816784
J Neurosci. 2005 Oct 5;25(40):9096-101
16207868
Nature. 1997 May 29;387(6632):500-5
9168112
Arch Neurol. 2010 Jan;67(1):80-6
20065133
J Comp Neurol. 2003 Feb 17;456(4):375-83
12532409
Neurobiol Dis. 2002 Jun;10(1):8-19
12079399
J Neurosci. 2005 Aug 3;25(31):7278-87
16079410
Proc Natl Acad Sci U S A. 1999 Apr 27;96(9):5274-9
10220456
Brain Res. 1994 Dec 15;666(2):151-67
7882025
Nat Neurosci. 2004 Nov;7(11):1181-3
15475950
Eur J Neurosci. 2001 Aug;14(4):629-44
11556888
Neurobiol Aging. 2002 May-Jun;23(3):335-48
11959395
Science. 2003 Dec 5;302(5651):1760-5
14615545
Ann N Y Acad Sci. 2007 Feb;1097:30-9
17413007
Exp Neurol. 2007 Mar;204(1):77-87
17070803
J Neurosci. 2009 Oct 28;29(43):13532-42
19864566
Int J Cancer. 1983 Jan 15;31(1):13-20
6339421
Eur J Neurosci. 2004 Jan;19(2):234-46
14725617
PLoS One. 2008 Apr 09;3(4):e1959
18509506
Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13363-7
15340159
N Engl J Med. 2003 Jun 19;348(25):2508-16
12815136
Neurobiol Dis. 2003 Aug;13(3):246-53
12901839
Prog Brain Res. 2000;127:35-48
11142036
Acta Neuropathol. 2008 Oct;116(4):419-24
18483741
Neuron. 1996 Jul;17(1):181-90
8755489
Neurobiol Aging. 2009 Jul;30(7):1078-90
18053619
J Biol Chem. 1996 Sep 20;271(38):23380-8
8798542